KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Cash & Current Investments (2016 - 2025)

Elevance Health (ELV) has disclosed Cash & Current Investments for 17 consecutive years, with $35.0 billion as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Current Investments rose 289.75% to $35.0 billion in Q3 2025 year-over-year; TTM through Dec 2025 was $53.6 billion, a 59.95% increase, with the full-year FY2024 number at $33.5 billion, up 395.77% from a year prior.
  • Cash & Current Investments was $35.0 billion for Q3 2025 at Elevance Health, up from $33.9 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $38.0 billion in Q2 2023 to a low of $165.0 million in Q3 2023.
  • A 5-year average of $21.3 billion and a median of $26.7 billion in 2022 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: tumbled 98.41% in 2023, then skyrocketed 5341.82% in 2024.
  • Elevance Health's Cash & Current Investments stood at $6.8 billion in 2021, then increased by 23.35% to $8.3 billion in 2022, then dropped by 19.0% to $6.8 billion in 2023, then soared by 395.77% to $33.5 billion in 2024, then rose by 4.5% to $35.0 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Cash & Current Investments are $35.0 billion (Q3 2025), $33.9 billion (Q2 2025), and $32.9 billion (Q1 2025).